Clinical trials
Liver Diseases trials in China with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
26 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 1 |
| 2011 | 2 |
| 2012 | 3 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 1 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 7 |
| 2023 | 1 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 26 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| The Second Affiliated Hospital of Chongqing Medical University | 2 |
| Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 2 |
| Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 1 |
| Chinese Medical Association | 1 |
| First Affiliated Hospital of Wenzhou Medical University | 1 |
| First Affiliated Hospital of Zhejiang University | 1 |
| Huashan Hospital | 1 |
| Institute of Hematology & Blood Diseases Hospital, China | 1 |
| Junqi Niu | 1 |
| Nanfang Hospital, Southern Medical University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Liver Diseases | 26 |
| Digestive System Diseases | 3 |
| COVID-19 | 2 |
| Carcinoma | 2 |
| Carcinoma, Hepatocellular | 2 |
| Fibrosis | 2 |
| Hepatitis | 2 |
| Liver Neoplasms | 2 |
| Acquired Immunodeficiency Syndrome | 1 |
| Adenocarcinoma | 1 |
Trials
Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.